KALETRA is an HIV-1 protease inhibitor indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients (14 days and older). Document Date Thursday, June 1, 2023 Last Reviewed Date Thursday, June 1, 2023 - 12:00 Lopinavir Ritonavir (Kaletra) PI_dated April 2023.pdf
Last Reviewed Date Thursday, June 1, 2023 - 12:00 Lopinavir Ritonavir (Kaletra) PI_dated April 2023.pdf
